Filtered By:
Condition: Hypertension
Management: Health Insurance
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 330 results found since Jan 2013.
Telmisartan use and risk of dementia in type 2 diabetes patients with hypertension: A population-based cohort study
by Chi-Hung Liu, Pi-Shan Sung, Yan-Rong Li, Wen-Kuan Huang, Tay-Wey Lee, Chin-Chang Huang, Tsong-Hai Lee, Tien-Hsing Chen, Yi-Chia Wei
BackgroundAngiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN). However, whether telmisartan, an ARB with peroxisome proliferator-activated receptor γ (PPAR-γ)–modulating effects, has additional benefits compared to other ARBs remains unclear. Methods and findingsBetween 1997 and 2013, 2,166,944 type 2 diabetes mellitus (T2DM) patients were identified from the National Health Insurance Research Database of Taiwa...
Source: PLoS Medicine - July 19, 2021 Category: Internal Medicine Authors: Chi-Hung Liu Source Type: research
Association between Coronary Artery Spasm and the risk of incident Diabetes: A Nationwide population-based Cohort Study
Conclusion: CAS is a risk factor for incident diabetes regardless of sex. However, females aged <50 years have a more apparent risk for CAS-related diabetes than old females, which is not observed in males. The median time of 2.9 years to incident diabetes warrants close follow-up.PMID:34104095 | PMC:PMC8176166 | DOI:10.7150/ijms.57987
Source: International Journal of Medical Sciences - June 9, 2021 Category: Biomedical Science Authors: Ming-Jui Hung Nen-Chung Chang Patrick Hu Tien-Hsing Chen Chun-Tai Mao Chi-Tai Yeh Ming-Yow Hung Source Type: research
